Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,021 | -4,840 | -2,122 | -824 | -7,757 |
| Depreciation Amortization | 633 | 449 | 287 | 137 | 470 |
| Accounts receivable | -3,762 | -3,053 | -1,895 | -365 | -2,655 |
| Accounts payable and accrued liabilities | 503 | -108 | -486 | -292 | -301 |
| Other Working Capital | -2,741 | -2,874 | -2,010 | -767 | -2,894 |
| Other Operating Activity | 6,899 | 4,962 | 3,393 | 1,231 | 5,126 |
| Operating Cash Flow | $-6,489 | $-5,463 | $-2,833 | $-880 | $-8,011 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -629 | -442 | -191 | -81 | -426 |
| Purchase Sale Intangibles | -179 | -138 | -46 | -4 | -531 |
| Other Investing Activity | -179 | -138 | -46 | -4 | -531 |
| Investing Cash Flow | $-808 | $-579 | $-237 | $-86 | $-957 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,595 | 1,726 | 1 | N/A | 16,453 |
| Other Financing Activity | -188 | -133 | -89 | -39 | -148 |
| Financing Cash Flow | $6,407 | $1,593 | $-88 | $-39 | $16,305 |
| Exchange Rate Effect | -4 | -3 | -2 | -2 | 4 |
| Beginning Cash Position | 9,042 | 9,042 | 9,042 | 9,042 | 1,700 |
| End Cash Position | 8,149 | 4,590 | 5,882 | 8,034 | 9,042 |
| Net Cash Flow | $-893 | $-4,452 | $-3,160 | $-1,007 | $7,341 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,489 | -5,463 | -2,833 | -880 | -8,011 |
| Capital Expenditure | -629 | -442 | -191 | -81 | -426 |
| Free Cash Flow | -7,117 | -5,905 | -3,024 | -962 | -8,437 |